Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

[68Ga]Pentixafor allows PET imaging of CXCR4 expression in humans

Oct. 1, 2013

Scientists create zebrafish model of hyperammonemia

Oct. 1, 2013

Long-acting GLP-1 analogue shows promise in diabetic mice

Sep. 30, 2013

Researchers from PharmaMar present first-in-human results for PM-060184

Sep. 30, 2013

Phase I results show promising oncolytic activity for the anti-HB-EGF antibody U3-1565

Sep. 30, 2013

Experimental LTC4S gene overexpression replicates aspirin-induced asthma

Sep. 27, 2013

Alnylam Pharmaceuticals reports interim results from phase I ALN-TTRsc trial

Sep. 27, 2013

Gemigliptin is safe and efficient as a long-term treatment added to ongoing metformin

Sep. 27, 2013

Torrent Pharmaceuticals presents first clinical data for TRC-150094

Sep. 27, 2013

Stanford University presents 64Cu-NOTA-B-Fab, an immuno-PET tracer companion diagnostic

Sep. 27, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...